MENU
+Compare
RNAC
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$10.68
Change
-$0.78 (-6.81%)
Capitalization
276.02M

RNAC Cartesian Therapeutics Forecast, Technical & Fundamental Analysis

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RNAC with price predictions
Jun 27, 2025

RNAC's RSI Oscillator climbs out of oversold territory

The RSI Indicator for RNAC moved out of oversold territory on May 28, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 43 similar instances when the indicator left oversold territory. In of the 43 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on RNAC as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for RNAC just turned positive on May 29, 2025. Looking at past instances where RNAC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

RNAC moved above its 50-day moving average on June 25, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RNAC advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RNAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RNAC broke above its upper Bollinger Band on June 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RNAC entered a downward trend on June 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RNAC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RNAC's P/B Ratio (588.235) is very high in comparison to the industry average of (16.366). P/E Ratio (1.995) is within average values for comparable stocks, (58.189). RNAC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (7.027) is also within normal values, averaging (252.247).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RNAC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RNAC is expected to report earnings to rise 32.35% to -89 cents per share on May 09

Cartesian Therapeutics RNAC Stock Earnings Reports
Q1'24
Est.
$-0.90
Q1'25
Missed
by $0.01
Q4'24
Beat
by $0.48
Q4'23
Missed
by $1.47
Q3'23
Missed
by $1.28
The last earnings report on May 08 showed earnings per share of -68 cents, missing the estimate of -67 cents. With 300.63K shares outstanding, the current market capitalization sits at 276.02M.
A.I. Advisor
published General Information

General Information

a developer of targeted immunotherapies and vaccines to treat and prevent diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
704 Quince Orchard Road
Phone
+1 617 923-1400
Employees
38
Web
https://www.cartesiantherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NROM0.210.03
+17.97%
Noble Roman's, Inc.
KHNGF221.75N/A
N/A
Kuehne & Nagel International AG
PPASF1.55N/A
N/A
Pick n' Pay Stores Ltd.
SHKLY124.00N/A
N/A
Sinotruk Hong Kong Ltd.
LEAT9.02N/A
-0.01%
Leatt Corp.

RNAC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-6.81%
WINT - RNAC
94%
Closely correlated
+21.49%
NCNA - RNAC
92%
Closely correlated
N/A
NBY - RNAC
91%
Closely correlated
+0.97%
SNPX - RNAC
91%
Closely correlated
+23.37%
SNGX - RNAC
89%
Closely correlated
-0.73%
More

Groups containing RNAC

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-6.81%
RNAC
(19 stocks)
26%
Poorly correlated
-0.54%